Evidence map›Paper›PMID 33278334›Full record

ArticleClinical and translational science2021

Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT-1: Influence on

Vijaya L Damaraju, Maral Aminpour, Michelle Kuzma, Philip Winter, Jordane Preto, Jack Tuszynski, Alexander B J McEwan, Michael B Sawyer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Vijaya L DamarajuDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Maral AminpourDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Michelle KuzmaDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Philip WinterDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Jordane PretoDepartment of Physics, University of Alberta, Edmonton, Alberta, Canada.
Jack TuszynskiDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Alexander B J McEwanDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada.
Michael B SawyerDepartment of Oncology, University of Alberta, Edmonton, Alberta, Canada.
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Positron emission tomography (PET) using 2-deoxy-2-[

Indexed as

Binding SitesCell Line, TumorDrug InteractionsFluorodeoxyglucose F18GlucoseGlucose Transporter Type 1HumansMolecular Docking SimulationPositron-Emission TomographyProtein BindingProtein Kinase InhibitorsFluorodeoxyglucose F18GlucoseGlucose Transporter Type 1Protein Kinase InhibitorsSLC2A1 protein, human

Identifiers

PMID33278334
PMCPMC8212708
OpenAlexW3112691602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.